Diabetes and COVID-19
56 results
1 - 56
Diabetes and COVID-19- DEFINITION
- EPIDEMIOLOGY
- DIAGNOSIS
- SIGNS AND SYMPTOMS
- COVID-19 infection in the adult population
- COVID-19 infection in the pediatric population
- Concerning symptoms in patients with preexisting diabetes
- CLINICAL TREATMENT
- Outpatient diabetes management in patients with COVID-19
- Inpatient diabetes management in patients with COVID-19
- FOLLOW UP
- EXPERT COMMENTS
- References
Molnupiravir
Molnupiravir- Nirmatrelvir/Ritonavir
- Nirmatrelvir/Ritonavir
- Sotrovimab
- Bebtelovimab
COVID-19 Update: Therapies and Vaccines- COVID-19: What We are Learning About this New Coronavirus
- COVID-19: Are We Getting Ahead?
- A COVID-19 Conversation - Variants, Vaccines, and Long-Term Effects
- Bamlanivimab
- Bamlanivimab and Etesevimab
- Bamlanivimab and Etesevimab
Health Alert Network (HAN)- COVID-19 Update with Dr. Paul Auwaerter of Johns Hopkins : Omicron Variant, Testing, and Treatment
- Remdesivir
- Remdesivir
- Coronavirus COVID-19 (SARS-CoV-2)
- Coronavirus COVID-19 (SARS-CoV-2)
- Casirivimab and Imdevimab
- Casirivimab and Imdevimab
- Steroid-induced Diabetes
Mindfulness During COVID-19- When to Refer
- Zygomycetes
- Nephropathy, HIV-Associated (HIVAN)
- Influenza Immunization and Chemoprophylaxis